XML 58 R43.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Taxes  
Schedule of Domestic and Foreign Components of Income (Loss) before Income Taxes

Year Ended December 31,

2025

2024

Domestic

$

32,032

$

(19,411)

Foreign

(217)

(68)

Income (loss) before income taxes

$

31,815

$

(19,479)

 

Schedule of Provision for Income Taxes (All Current)

Year Ended December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

Current:

Federal

$

$

State

Foreign

Total current tax expense (benefit)

$

$

Deferred:

Federal

$

$

(5,483)

State

 

 

(175)

Foreign

103

Total deferred tax expense (benefit)

$

103

$

(5,658)

 

Reconciliation Between the Tax Provision Computed at the Federal Statutory Income Tax Rate and Actual Effective Income Tax Rate

Year Ended December 31, 2025

Amount

Percent

U.S. federal statutory tax rate

$

6,681

21

%

State and local income taxes, net of federal income tax effect

%

Foreign tax effects

103

%

Effect of cross-border tax laws

%

Effect of changes in tax laws or rates enacted in the current period:

Tax credits

%

Changes in Valuation Allowances

(2,538)

(8)

%

Nontaxable or nondeductible items:

Stock based compensation

(584)

(2)

%

Nondeductible executive compensation

735

2

%

Bargain purchase gain

(4,457)

(14)

%

Other permanent differences

163

1

%

Changes in unrecognized tax benefits

%

Effective tax rate

$

103

%

 

Year Ended December 31, 

 

  ​ ​ ​

2024

 

Federal tax at statutory rate

 

21

%

Stock compensation and other permanent differences

 

(2)

%

Nondeductible executive compensation

 

(2)

%

Bargain purchase gain

20

%

Tax benefit related to Pulmokine acquisition

29

%

Valuation allowance

 

(37)

%

Total

 

29

%

 

Schedule of Total Cash Paid for Income Taxes, Net of Refunds

Federal

$

277

State

Foreign

Total cash paid for income taxes, net of refunds

$

277

 

Components of Net Deferred Tax Assets

December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

Capitalized research and development expenses

$

80,267

$

22,663

Net operating loss carryforwards

 

42,946

 

36,675

Research and development and other tax credit carryforwards

 

13,176

 

13,176

Stock compensation

 

4,930

 

5,577

Unearned revenue

 

960

 

1,250

Royalty receivable

10,931

10,717

Lease liabilities

4,850

201

Intangible Asset

6,603

Other

 

658

 

585

Subtotal

 

165,321

 

90,844

Less: valuation allowance

(159,927)

(85,160)

Total net deferred tax assets

5,394

5,684

Right-of-use assets

(55)

(69)

Intangible liability

(5,339)

(5,615)

Total deferred tax liabilities

 

(5,394)

(5,684)

Net deferred tax liabilities

$

$

 

Schedule of Unrecognized Tax Benefits

Year Ended December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

Balance as of January 1

$

5,938

$

5,938

Increase related to current year tax position

 

 

(Decrease) Increase related to prior year tax position

 

 

Balance as of December 31

$

5,938

$

5,938